Literature DB >> 2065690

Response of recurrent giant cell myocarditis in a transplanted heart to intensive immunosuppression.

G Kong1, B Madden, N Spyrou, A Pomerance, A Mitchell, M Yacoub.   

Abstract

A 35-year-old man developed giant cell myocarditis resulting in severe congestive cardiac failure. He needed urgent orthotopic cardiac transplantation despite maximal doses of inotropes and augmentation with an intra-aortic balloon pump. The patient presented with rhythm disturbances and echocardiographically diminished ventricular function at subsequent follow-up. Biopsies then taken revealed recurrence of myocarditis in the transplanted heart. Investigations revealed no obvious cause for the myocardial granulomas nor any evidence of systemic granulomatous disease. The patient received, in addition to maintenance cyclosporin A and azathioprine, high doses of corticosteroids which resulted in complete resolution of the inflammatory process and no recurrence has been detected to date. This case shows that giant cell myocarditis can recur in the transplanted heart despite routine immunosuppression with azathioprine and cyclosporin A and that additional treatment with high dose corticosteroids is effective in causing regression of the inflammatory process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065690     DOI: 10.1093/oxfordjournals.eurheartj.a059938

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  11 in total

1.  Autoimmune sensitization to cardiac myosin leads to acute rejection of cardiac allografts in miniature swine.

Authors:  Gregory R Veillette; Hisashi Sahara; Andrew J Meltzer; Mathew J Weiss; Yoshiko Iwamoto; Karen M Kim; Bruce R Rosengard; James S Allan; Stuart L Houser; David H Sachs; Gilles Benichou; Joren C Madsen
Journal:  Transplantation       Date:  2011-06-15       Impact factor: 4.939

Review 2.  Cardiac Autoimmunity: Myocarditis.

Authors:  William Bracamonte-Baran; Daniela Čiháková
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 3.  Small steps for idiopathic giant cell myocarditis.

Authors:  Jeffrey A Shih; Jennifer A Shih
Journal:  Curr Heart Fail Rep       Date:  2015-06

Review 4.  Recognition and optimum management of myocarditis.

Authors:  A L Caforio; W J McKenna
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

5.  Fatal giant cell myocarditis after resection of thymoma.

Authors:  P E Glennon; M E Petersen; M N Sheppard
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

6.  Thymoma associated with fatal myocarditis and polymyositis in a 58-year-old man following treatment with carboplatin and paclitaxel: A case report.

Authors:  Hidefumi Sasaki; Motoki Yano; Osamu Kawano; Yu Hikosaka; Yoshitaka Fujii
Journal:  Oncol Lett       Date:  2011-11-30       Impact factor: 2.967

Review 7.  Idiopathic giant cell myocarditis and cardiac sarcoidosis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

8.  Idiopathic Giant Cell Myocarditis.

Authors:  Leslie T. Cooper; Yuji Okura
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-12

Review 9.  Innovative drug treatments for viral and autoimmune myocarditis.

Authors:  S Anandasabapathy; W H Frishman
Journal:  J Clin Pharmacol       Date:  1998-04       Impact factor: 3.126

10.  Diagnosis and management of viral myocarditis.

Authors:  William H Frishman; Joshua Zeidner; Nauman Naseer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.